表观遗传时钟与白细胞端粒长度同维生素D状态相关,但与功能评估及衰弱无关:柏林老龄化研究II
该横断面研究纳入柏林老龄化研究II的1,649名参与者,分析DNA甲基化年龄加速与相对白细胞端粒长度(rLTL)是否与维生素D缺乏及功能评估(含Fried衰弱评分)相关。结果显示维生素D充足者DNAm年龄加速更低、rLTL更长,但两种衰老生物标志物均与Fried衰弱评分及功能评估无显著关联,仅画钟测验在老年男性亚组中与DNAm年龄加速相关。
要点
- 维生素D充足者较缺乏者DNAm年龄加速低1.4年、rLTL长0.11。
- DNAm年龄加速与rLTL均与Fried衰弱评分及功能评估无显著关联。
- 仅老年男性亚组画钟测验与DNAm年龄加速相关(β=1.898,p=.002)。
核心结论
- 表观遗传时钟与rLTL同维生素D状态相关,但与Fried衰弱评分及功能评估无显著关联。
- 两种衰老生物标志物能否预测个体功能状态或与衰弱进程相关,尚待纵向研究阐明。
研究设计与样本
- 柏林老龄化研究II的横断面分析,纳入1,649名参与者(约50%女性,年龄22-37岁和60-84岁)。
- 采用7个CpG位点时钟估算DNAm年龄加速,以定量实时PCR测量rLTL。
- 25(OH)D血清水平<25 nmol/L定义为维生素D缺乏,<50 nmol/L定义为维生素D不足。
主要发现
- 维生素D充足者平均DNAm年龄加速较缺乏者低1.4年(p<.05,方差分析)。
- 维生素D充足者rLTL较缺乏者长0.11(p<.001,方差分析)。
- 协变量校正分析中,维生素D充足者DNAm年龄加速更低(β=1.060,p=.001)、rLTL更长(β=-0.070,p<.001)。
- DNAm年龄加速与rLTL均与Fried衰弱评分及功能评估无显著关联。
- 仅画钟测验与DNAm年龄加速相关(老年男性亚组:β=1.898,p=.002)。
关键数值与推荐
- 维生素D缺乏:25(OH)D血清水平<25 nmol/L;维生素D不足:<50 nmol/L。
- DNAm年龄加速通过7个CpG位点时钟估算。
临床怎么用
- 解读老年人维生素D状态时可参考其与DNAm年龄加速及rLTL的关联,但不应据此推断功能状态或衰弱程度。
- DNAm年龄加速与rLTL目前不宜作为评估老年人功能能力或衰弱的常规生物标志物。
局限性
- 为横断面设计,无法判断因果或预测价值。
- 生物标志物与功能评估及衰弱的关联需未来纵向分析进一步阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
DNA methylation (DNAm) age acceleration, a parameter derived via the epigenetic clock, has recently been suggested as a biomarker of aging. We hypothesized that accelerated biological aging, measured by both this new and the established biomarker of aging, relative leukocyte telomere length (rLTL), are associated with vitamin D deficiency. Moreover, we tested for an association between rLTL/DNAm age acceleration and different clinical assessments for functional capacity, including the Fried frailty score. Cross-sectional data of 1,649 participants of the Berlin Aging Study II was available (~50% female, age: 22-37 and 60-84 years). A seven cytosine-phosphate-guanine clock was estimated to calculate the DNAm age acceleration. rLTL was measured by quantitative real-time polymerase chain reaction (PCR). 25-hydroxyvitamin D (25(OH)D) serum levels <25 nmol/L was defined as vitamin D deficiency and <50 nmol/L as vitamin D insufficiency. Vitamin D-sufficient individuals had a 1.4 years lower mean DNAm age acceleration (p < .05, analysis of variance [ANOVA]) and a 0.11 longer rLTL (p < .001, ANOVA) than vitamin D-deficient participants. Likewise, vitamin D-sufficient participants had lower DNAm age acceleration (β = 1.060, p = .001) and longer rLTL (β = -0.070; p < .001) than vitamin D nonsufficient subjects in covariate-adjusted analysis. Neither DNAm age acceleration nor rLTL were significantly associated with the Fried frailty score or the functional assessments. Only the clock drawing test was associated with DNAm age acceleration (subgroup of older men: β = 1.898, p = .002). Whether the analyzed biomarkers of aging can be used to predict an individual's functional capacity or will be associated with frailty in the advanced course of aging, will be clarified by future longitudinal analyses.
引用
- Vetter VM, Spira D, Banszerus VL, et al. Epigenetic Clock and Leukocyte Telomere Length Are Associated with Vitamin D Status but not with Functional Assessments and Frailty in the Berlin Aging Study II. J Gerontol A Biol Sci Med Sci. 2020. PMID: 32324874. doi:10.1093/gerona/glaa101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。